Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antidepressant MedGuide Distribution Imminent; Unit-Of-Use Packs To Follow

Executive Summary

The new patient Medication Guide for prescription antidepressants is expected to be in pharmacies beginning the week of March 7

You may also be interested in...



As Medication Guide Requirements Increase, FDA Considers Electronic Delivery

FDA is considering electronic distribution of Medication Guides as their use increases and questions are raised about whether they are consistently reaching patients

As Medication Guide Requirements Increase, FDA Considers Electronic Delivery

FDA is considering electronic distribution of Medication Guides as their use increases and questions are raised about whether they are consistently reaching patients

FDA Drug Risk Communication Should Include Drug Benefit Info, PhRMA Says

FDA risk communication materials should include information about a drug's benefits to avoid scaring patients away from their medications, the Pharmaceutical Research & Manufacturers of America said

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS045453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel